Featured Research

from universities, journals, and other organizations

Preventing Friendly Fire: A Role For The Thymic Cortex In Stopping Your Body From Attacking Itself

Date:
August 6, 2008
Source:
Public Library of Science
Summary:
A new study investigates the inner mechanics of the thymus, the organ that creates the foot soldiers of the immune system. The study helps shed light on the timing and regulation of negative selection, a crucial developmental process.

In order to effectively prevent disease, the immune system must be able to distinguish between self and non-self, and to selectively target the latter. The process that removes immune cells that would otherwise react to the body – engage in friendly fire – is called negative selection.

A new paper published in this week's PLoS Biology, the online open access journal, investigates the inner mechanics of the thymus, the organ that creates the foot soldiers of the immune system. The paper, by Sejin Ahn and colleagues, helps shed light on the timing and regulation of negative selection, a crucial developmental process.

The thymus creates T cells, white blood cells that destroy harmful material as part of the immune response to pathogens. Many more immature T cells are created than are allowed to develop, and the filtering processes – which select only those immature cells that can be useful – occurs within the thymus. The thymus is roughly divided into two main regions, the medulla and the cortex. It has previously been unclear whether the cortex is involved in negative selection, or whether this process is restricted to the medulla.

The new paper, a collaboration between researchers from the US, Korea and the UK, has changed this. The authors have genetically engineered mice to contain an antigen, LacZ, in only a small fraction of the cells of the cortex and nowhere else in the body. They found that any T cells that were programmed to attack LacZ were absent from the mature mice. As the T cells could only have been exposed to LacZ in the cortex, this is strong evidence the cortex has removed them before they reach the rest of the body. Therefore the cortex also has a role in negative selection and significantly tolerizes the developing T cells with impressive efficiency.

This research allows a much clearer understanding of the internal mechanics of the thymus, and how negative selection might work.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ahn S, Lee G, Yang SJ, Lee D, Lee S, et al. TSCOT+ Thymic Epithelial Cell-Mediated Sensitive CD4 Tolerance by Direct Presentation. PLoS Biol, 2008; 6(8): e191 DOI: 10.1371/journal.pbio.0060191

Cite This Page:

Public Library of Science. "Preventing Friendly Fire: A Role For The Thymic Cortex In Stopping Your Body From Attacking Itself." ScienceDaily. ScienceDaily, 6 August 2008. <www.sciencedaily.com/releases/2008/08/080804222908.htm>.
Public Library of Science. (2008, August 6). Preventing Friendly Fire: A Role For The Thymic Cortex In Stopping Your Body From Attacking Itself. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/08/080804222908.htm
Public Library of Science. "Preventing Friendly Fire: A Role For The Thymic Cortex In Stopping Your Body From Attacking Itself." ScienceDaily. www.sciencedaily.com/releases/2008/08/080804222908.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins